Citadel Advisors
CNSY

Citadel Advisors’s Cerenome, Inc. Common Stock CNSY Stock Holding History

Citadel Advisors’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Hold
0
– -$25K – 7941
2017
Q1 		– Hold
0
– – – 7203
2016
Q4 		– Hold
0
– – – 7051
2016
Q1 		– Hold
0
– -$3K – 7719
2015
Q4 		– Hold
0
– – – 8539
2015
Q3 		– Hold
0
– – – 8633
2015
Q1 		– Hold
0
– -$1K – 8781
2014
Q4 		– Hold
0
– – – 8417
2014
Q3 		– Hold
0
– – – 7917
2014
Q2 		– Hold
0
– – – 7696
2014
Q1 		– Hold
0
– – – 7517
2013
Q4 		– Hold
0
– – – 6822
2013
Q3 		– Hold
0
– – – 6007
2013
Q2 		– Hold
0
– – – 5955

Other funds holding CNSY

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Citadel Advisors's CNSY Position: Q1 2026 in Review

Citadel Advisors sold out of Cerenome, Inc. Common Stock (CNSY) in Q1 2026, closing a stake of 7,402 shares — an estimated $94.8K sold.

Citadel Advisors first reported a position in CNSY in Q1 2019 and held it in 12 quarters. The position peaked at $111K in Q2 2021. 23 funds tracked by Wall St. Rank hold CNSY as of Q1 2026.

  • Citadel Advisors reported no remaining Cerenome, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 7,402 Cerenome, Inc. Common Stock shares in Q1 2026, an estimated $94.8K.
  • Citadel Advisors first reported a position in Cerenome, Inc. Common Stock in Q1 2019 and held it in 12 quarters.
  • Citadel Advisors's Cerenome, Inc. Common Stock position peaked at $111K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Cerenome, Inc. Common Stock as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.